| Literature DB >> 32448835 |
Kentaro Tominaga1, Atsunori Tsuchiya1, Hiroki Sato1, Takeshi Mizusawa1, Shinichi Morita2, Yui Ishii1, Nobutaka Takeda1, Kazuki Natsui1, Yuzo Kawata1, Naruhiro Kimura1, Yoshihisa Arao1, Kazuya Takahashi1, Kazunao Hayashi1, Junji Yokoyama1, Shuji Terai1.
Abstract
Ulcerative colitis, a chronic and recurrent inflammatory disease, is localized to the colonic mucosa but can affect other organs and lead to various complications. Gastroduodenitis associated with ulcerative colitis has been reported. However, little is known about esophageal ulcers. We herein report two rare cases of esophageal ulcers associated with ulcerative colitis. Furthermore, the clinical and histological characteristics of 18 previously reported cases are summarized. This case series and literature review will encourage the accurate diagnosis and treatment of esophageal ulcers associated with ulcerative colitis.Entities:
Keywords: esophageal ulcer; manifestation; ulcerative colitis
Mesh:
Year: 2020 PMID: 32448835 PMCID: PMC7492127 DOI: 10.2169/internalmedicine.4437-20
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
Figure 1.Esophagogastroduodenoscopy (EGD), colonoscopy, and their pathological findings. (a) EGD showing an ulcer with aphthae (arrows) in the mid intrathoracic esophagus. (b) EGD showing widespread aphthae (arrowheads) at the antrum. (c) Colonoscopy showing erythema and mucosal friability in the sigmoid colon. (d) Biopsy specimen from the esophageal ulcers showing severe inflammatory cell infiltration [Hematoxylin and Eosin (H&E) staining, ×100]. (e) Biopsy specimen from the colon showing inflammatory cell infiltration with cryptitis in the rectum (H&E staining, ×100).
Figure 2.Esophagogastroduodenoscopy (EGD) and colonoscopic findings. (a) EGD showing marked healing of the esophageal ulcers (arrows). (b) EGD showing healing of the gastroduodenal aphthae. (c) Colonoscopy showing improvement of mucosal edema and vascular appearance of the sigmoid colon.
Figure 3.Esophagogastroduodenoscopy (EGD), colonoscopy, and their pathological findings. (a) EGD showing a longitudinal ulcer in the lower esophagus. (b) Colonoscopy showing mucosal friability in the rectum. (c) Colonoscopy showing mucosal friability in the terminal ileum. (d) Biopsy specimen from the esophageal ulcers showing infiltration of inflammatory cells in the epithelia [Hematoxylin and Eosin (H&E) staining, ×100]. (e) Biopsy specimen from the rectum showing inflammatory cell infiltration with basal plasmacytosis and cryptitis (H&E staining, ×100).
Figure 4.Esophagogastroduodenoscopy (EGD) and colonoscopic findings. (a) EGD showing healing of the esophageal ulcers. (b) Colonoscopy showing remission of the rectum.
Clinical Data of UC Patients with Esophageal Ulcer.
| Case | Ref | Age | Sex | Duration | UC phase | Type | UC treatment |
|---|---|---|---|---|---|---|---|
| 1 | Ours | 16 | F | 0 | Active | Total | PSL |
| 2 | Ours | 19 | F | 0 | Active | Total | PSL |
| 3 | 6 | 15 | M | 2 years | Remission | Left side | PSL, SASP |
| 4 | 7 | 23 | M | 5 years | Remission | Total | PSL, SASP |
| 5 | 8 | 21 | F | 0 | Active | N/A | PLS, SASP |
| 6 | 19 | M | 0 | Active | N/A | N/A | |
| 7 | 10 | 47 | F | 0 | Active | Right side | 5ASA |
| 8 | 4 | 18 | F | 7 years | Relapse Active | Total | SASP |
| 9 | 11 | 18 | M | 1 year | Active | Left side | PSL, 5ASA |
| 10 | 12 | 19 | M | 0 | Active | Total | none |
| 11 | 13 | 51 | M | 0 | Active | Total | PSL, 5ASA |
| 12 | 14 | 33 | M | 0 | Active | Total | PSL, LCAP |
| 13 | 15 | 52 | F | 3 years | Relapse Active | Left side | SASP |
| 14 | 5 | 28 | M | 17 years | Post operation | Total | Total colectomy and ileostomy |
| 15 | 8 | 26 | M | 2 months | Post operation | Total | Sbtotal colectomy and ileostomy |
| 16 | 14 | F | 5 years | Post operation | Total | Sbtotal colectomy and ileostomy | |
| 17 | 24 | M | 9 years | Post operation | Total | Total proctocolectomy | |
| 18 | 9 | 21 | M | 3 years | Post operation | Total | Total colectomy and ileostomy |
| 19 | 16 | 47 | M | 21 years | Post operation | N/A | Sbtotal colectomy and ileostomy |
| 20 | 53 | M | N/A | Post operation | Total | Sbtotal colectomy |
UC: ulcerative colitis, N/A: data not available, PSL: prednisolone, SASP: salazosulfapyridine, 5-ASA: 5-aminosalicylic acid, F: female, M: male
Clinical Data of UC Patients with Esophageal Ulcer.
| Case (No) | Esophagial ulcer (EU) | Location | EU symptoms |
|---|---|---|---|
| 1 | An esophageal ulcer with aphthae | Middle esophagus | Chest pain |
| 2 | Longitudinal oesophageal ulcer | Lower esophagus | Chest pain on swallowing |
| 3 | Severe esophagitis | Lower esophagus | Parasternal chest pain and dysphagia |
| 4 | Shallow ulceration with gross diffuse irregularity and polyp formation | Middle and lower esophagus | Dysphagia |
| 5 | Active ulcerative esophagitis | N/A | N/A |
| 6 | Marked ulcerative esophagitis | N/A | Substenal pain and dysphagia |
| 7 | Multiple irregular esophageal ulcers | Whole esophagus | Anterior chest pain and dysphagia |
| 8 | Longitudinal oesophageal ulcer with haemorrhage | Middle and lower esophagus | Sore throat and pain on swallowing |
| 9 | Punched-out esophageal ulcer | Middle esophagus | Sore throat and anterior chest pain |
| 10 | Punched-out esophageal ulcer | Middle esophagus | General fatigue |
| 11 | Punched-out esophageal ulcer | Middle and lower esophagus | Anterior chest pain on swallowing |
| 12 | Punched-out esophageal ulcer | Middle and lower esophagus | Anterior chest pain and dysphagia |
| 13 | Punched-out esophageal ulcer | Middle esophagus | Anterior chest pain on swallowing |
| 14 | Web formation | Middle esophagus | No |
| 15 | Esophagial ulcerations with perforaton into the anterior mediastinum | N/A | Dysphagia, fever, hypotension |
| 16 | Necrotizing fibrinopurulent ulceration | N/A | N/A |
| 17 | Ulcerative and membranous esophagitis | N/A | Nausea, vomiting and hematemesis |
| 18 | Multiple friable ulcerations | Whole esophagus | Severe odynophagia and dyspahgia |
| 19 | Necrosis | Lower esophagus | Epigastric pain |
| 20 | Necrosis | Middle and lower esophagus | Hematemesis |
UC: ulcerative colitis, N/A: data not available
Clinical Data of UC Patients with Esophageal Ulcer.
| Case (No) | EU biopsy | EU treatment | Outcome of EU | Other complication |
|---|---|---|---|---|
| 1 | Severe inflammatory cell infiltration | PSL | Improvement | No |
| 2 | Infiltration of inflammatory cells in the epithelia and no specific information | PSL | Improvement | Oral ulcer |
| 3 | Superficial inflammation | PSL | Improvement | Maculopapular eruption |
| 4 | Chronically inflamed and edematous, with a dense infltrate of plasma cells, lymphocytes, and histocytes | PSL | Improvement | Buccal ulceration and arthritis |
| 5 | N/A | - | - | No |
| 6 | N/A | - | - | Necrotic ulceration in the inguinal, genital regions and lower extremities |
| 7 | Nonspecific findings other than inflammatorycell infiltration | 5ASA, H2blocker | Improvement | No |
| 8 | Nonspecific findings other than inflammatorycell infiltration | PSL | Improvement | No |
| 9 | Nonspecific findings (Appearance of regenerative epithelium) | PSL | Improvement | Oral ulcer and pancreatitis |
| 10 | Nonspecific findings | PSL, SASP | Improvement | No |
| 11 | Thickening of epithelial stratum spinosum without nuclear inclusion body | PPI | Improvement | No |
| 12 | Nonspecific findings (Appearance of regenerative epithelium) | PPI | Improvement | No |
| 13 | Nonspecific findings other than inflammatorycell infiltration | PSL | Improvement | No |
| 14 | N/A | PSL | N/A | Mouth and pyoderma gangrenosum |
| 15 | N/A | - | - | Oral ulcerations, pustular dermatitis, arthritis |
| 16 | N/A | - | - | N/A |
| 17 | N/A | - | - | Ulcar of his buttock, paronychia of hands |
| 18 | Dense infiltrate of polymorphonuclear cells, a few eosinophils and mononuclear cells | PSL, tetracycline | N/A | Arthritis, episcleritis, oral ulcerations and erythema nodosum |
| 19 | Inflammatory cell and infiltration | PPI | Stricture | No |
| 20 | Not examination | PPI | Stricture | No |
UC: ulcerative colitis, EU: esophageal ulcer, N/A: data not available, PSL: prednisolone, SASP: salazosulfapyridine, 5-ASA: 5-aminosalicylic acid, PPI: proton pump inhibitor